Chlamydia News and Research

Latest Chlamydia News and Research

New test could identify resistant tuberculosis faster

Tuberculosis (TB) disease rates in some parts of London are as high as in Sub-Saharan Africa, and drug-resistant strains are becoming increasingly common.

From Oxford Gene Technology 14 May 2015

UCL-led team develops new technique to find resistant TB faster

The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.

From Oxford Gene Technology 13 May 2015

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).

6 May 2015

New Johns Hopkins study finds occurrence of gonorrhea or chlamydia is significant in women

Current public health guidelines recommend that only gay men and people with HIV should be routinely screened for extragenital gonorrhea and chlamydia, given the high burden of these sexually transmitted infections (STIs) in this at-risk population.

29 Apr 2015

Symbiomix Therapeutics announces positive results from SYM-1219 Phase 1 clinical program

Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from its Phase 1 clinical program demonstrating that its lead product candidate, SYM-1219, was safe and well tolerated and had predictable pharmacokinetics (PK), and that contraceptive efficacy for birth control pills would not be altered by SYM-1219 administration.

4 Mar 2015

San Francisco AIDS Foundation unveils new mobile testing unit

On Valentine's Day, San Francisco AIDS Foundation unveiled a new mobile testing unit, an essential element in the plan to eliminate HIV transmission in San Francisco. The new unit—a 33-foot-long vehicle outfitted specifically for HIV and STI testing—will increase the availability of free testing in neighborhoods across the city at times when other HIV testing sites are closed.

19 Feb 2015

Overview of chlamydia trachomatis infections

RnRMarketResearch.com adds "Chlamydia Trachomatis Infections - Pipeline Review, H1 2015" research to its store.

8 Feb 2015

UTSA's Bernard Arulanandam named fellow of AAAS

Bernard Arulanandam, UTSA Jane and Roland Blumberg Professor in Biology and Assistant Vice President for Research Support, has been named a fellow of the American Association for the Advancement of Science. Arulanandam was elected by his peers for the honor, recognizing his scientific and socially distinguished efforts to advance science and its applications.

26 Nov 2014

New study documents health dangers of male sex trade in Mexico City

A new study documents the stark health dangers of the male sex trade in the streets, hotels, and discotheques of Mexico City. Lead author and health economist Omar Galárraga's point in making the grim assessment of the legal but perilous market is to find an incentive that might reduce the spread of HIV and other diseases in the nation's community of men who have sex with men.

16 Nov 2014

First three recipients of inaugural Harry Winston Fellowships named

Harry Winston, Inc. and the UCLA Children's Discovery and Innovation Institute have named the first three recipients of the inaugural Harry Winston Fellowships.

7 Oct 2014

Study: Sexual risk behaviors of young Hispanic people vary with degree of acculturation

A new study in the Journal of Adolescent Health finds that the sexual risk behaviors of young Hispanic people living in the U.S. vary considerably with their degree of acculturation (as defined by where they were born and the language they speak).

3 Sep 2014

Rice University researchers confirm potent synthesis of natural tetracycline

A fortuitous collaboration at Rice University has led to the total synthesis of a recently discovered natural antibiotic.

29 Aug 2014

Microbiologist receives contract from U.S. DOD to develop vaccine against tularemia

Microbiologist Karl Klose, a professor in the UTSA College of Sciences' Department of Biology and a member of the South Texas Center for Emerging Infectious Diseases, has received a contract from the U.S. Department of Defense (DOD) to conduct research that would bring scholars one step closer to developing a vaccine against tularemia.

14 Aug 2014

BD reports 5.1% increase in third fiscal quarter revenues

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly revenues of $2.157 billion for the third fiscal quarter ended June 30, 2014, representing an increase of 5.1 percent from the prior-year period, or 4.6 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 31 Jul 2014

Five-year $10.7M grant to study control, prevention of sexually-transmitted infections

The University of Maryland Schools of Dentistry (UM SOD) and Medicine (UM SOM) jointly announced today that they have received a five-year $10.7 million grant award from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to study the causes, prevention and treatment of sexually-transmitted diseases (STDs).

30 Jul 2014

Research roundup: Funding for safety-net hospitals; insurance competition

Safety-net hospitals rely on disproportionate-share hospital (DSH) payments to help cover uncompensated care costs and underpayments by Medicaid

9 Jun 2014

Roche's cobas HPV Test gets FDA approval for first-line primary screening for cervical cancer

Roche announced today that the U.S. Food and Drug Administration approved the cobas HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12 unanimous recommendation from the Microbiology Devices Panel of the FDA's Medical Devices Advisory Committee, making the cobas HPV Test the first and only HPV test in the United States approved for first-line primary screening.

From Roche Sequencing and Life Science 25 Apr 2014

Study: Immunization program in UK has reduced HPV infections in young women

Each year around 2,000-2,500 women are diagnosed with cervical cancer in England, the most common cancer in women under 35. Infection with high-risk human papillomavirus (HR HPV) types 16 and 18 is responsible for around 70-80% of cervical cancers.

15 Apr 2014

Experimental vaccine for HSV-2 infection reduces rate of viral shedding at 6 months

Updated Phase 1/2a results with GEN-003, a vaccine candidate under development by Genocea Biosciences, Inc. (Nasdaq: GNCA) for the treatment of herpes simplex virus type 2 (HSV-2) infection, showed the experimental vaccine to generate highly significant reductions in both the number of clinical lesion days and rate of viral shedding at six months after the final vaccine dose.

27 Mar 2014

More men contract chlamydia in Australia, finds new study

The largest Australian chlamydia study to date, led by the University of Melbourne, has found more men contract chlamydia than previously thought and most cases of infection are being missed.

17 Feb 2014

Chlamydia News and Research

Latest Chlamydia News and Research

New test could identify resistant tuberculosis faster

UCL-led team develops new technique to find resistant TB faster

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

New Johns Hopkins study finds occurrence of gonorrhea or chlamydia is significant in women

Symbiomix Therapeutics announces positive results from SYM-1219 Phase 1 clinical program

San Francisco AIDS Foundation unveils new mobile testing unit

Overview of chlamydia trachomatis infections

UTSA's Bernard Arulanandam named fellow of AAAS

New study documents health dangers of male sex trade in Mexico City

First three recipients of inaugural Harry Winston Fellowships named

Study: Sexual risk behaviors of young Hispanic people vary with degree of acculturation

Rice University researchers confirm potent synthesis of natural tetracycline

Microbiologist receives contract from U.S. DOD to develop vaccine against tularemia

BD reports 5.1% increase in third fiscal quarter revenues

Five-year $10.7M grant to study control, prevention of sexually-transmitted infections

Research roundup: Funding for safety-net hospitals; insurance competition

Roche's cobas HPV Test gets FDA approval for first-line primary screening for cervical cancer

Study: Immunization program in UK has reduced HPV infections in young women

Experimental vaccine for HSV-2 infection reduces rate of viral shedding at 6 months

More men contract chlamydia in Australia, finds new study

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chlamydia News and Research

Latest Chlamydia News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in